A core part of EMVC’s model is to develop a customized investment strategy for each company, so that the companies we work with have access to the right type of funding and support specific to their sector and stage of development. We achieve that by syndicating investment sources from the EMVC Evergreen EIS Fund, and network of investors from Family Offices, Wealth Managers, institutional VC investors and Corporate VC funds.
INVESTORS
REAL BUSINESSES, REAL INNOVATION, REAL VALUE
EMVC invest in B2B businesses built on core technological innovation, generating tangible economic value for the industrial sectors in the real economy.
STRONG CORPORATE LINKS
When Investing, we seek to leverage our network of corporate relationships both to validate the opportunities and to accelerate the growth of the Investee Companies.
FOLLOW ON CAPITAL AND CO-INVESTMENT
Our Portfolio companies benefit from access to follow-on funding, such as through EMVC’s contacts with institutional investors, corporate venturing teams and investment vehicles.
Selected Portfolio Companies
SECTORS OF INTEREST
ENERGY
Investing towards a significant positive contribution to the energy balance.
TRANSPORT
Technologies developing energy efficiency, autonomy, and monitoring in transport systems.
CIRCULAR ECONOMY
Supporting technologies designing circular industrial processes to tackle waste streams.
HEALTH TECH
Developing health benefits platforms, investing in innovation and research.
SMART CITY
Improving city assets and infrastructure using IoT and smart technologies.
INDUSTRIAL HIGH-TECH
Advancing the impact of robotics, IoT, and high-tech in industry.
FUNDING
We invest in and accelerate the growth of promising early-stage hardware companies with an innovative prototype. We invest in companies that are at a more advanced stage of development, and facilitate access to additional funding through our network.
LATEST NEWS
EMV Capital portfolio company Wanda Health, a leading virtual healthcare solutions provider, partners with Florida-based Smart Meter Corp to provide high quality data capture from patients
London, 4th April 2022 – EMV Capital today announced...
by EMV Capital Ltd
- Apr 04, 2022
EMV Capital advises on a restructuring and investment in Vortex Biotech Holdings. Appointment of new Vortex CEO to drive growth.
London, UK, 16th August 2022 – International venture capital investor...
- Aug 16, 2022
EMV Capital leads a £1.6m investment into Q-Bot Ltd, the UK’s leading developer of robotics in the construction & retrofit industry
EMV Capital announces that it has led a £1.6m...
- Jun 15, 2022
EMV Capital advises on a £2.8m transaction with portfolio company Q-Bot, a leader in construction industry robotics company Q-Bot
Acquisition of a direct stake of c.19% by NetScientific,...
- Dec 22, 2021
Martlet Capital Update: EMVC syndicates additional £0.73m investment
Syndication highlights strength of capital light investment model London,...
- Dec 13, 2021
Martlet Capital Update: EMV Capital syndicates additional £0.73m investment
Syndication highlights strength of capital light investment model London,...
- Dec 13, 2021
| Disclaimer
Investing in start-ups and early-stage businesses involves risks, including illiquidity, lack of dividends, loss of investment and dilution. Investments made in investee companies via funds managed by Sapphire Capital Partners LLP are not covered by the Financial Services Compensation Scheme (FSCS). For more details, please contact us or refer to their website: https://www.fscs.org.uk |